Monitoring, Immunologic
-
Subject Areas on Research
- 18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer. 30 October-2 November 2003, Bethesda, Maryland, USA.
- Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis.
- Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study.
- Combined simultaneous kidney/bone marrow transplantation.
- Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
- Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays.
- Development of a contemporary globally diverse HIV viral panel by the EQAPOL program.
- Development of tolerogenic strategies in the clinic.
- Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring.
- Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials.
- Immune monitoring.
- Immune profiling: molecular monitoring in renal transplantation.
- Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.
- Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL).
- Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.
- Laboratory Accuracy Improvement in the UK NEQAS Leucocyte Immunophenotyping Immune Monitoring Program: An Eleven-Year Review via Longitudinal Mixed Effects Modeling.
- Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs.
- Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I.
- Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.
- Premature translational termination products are rapidly degraded substrates for MHC class I presentation.
- Proteomics for monitoring immune responses to cancer vaccines.
- Quantitating cellular immune responses to cancer vaccines.
- Setting objective thresholds for rare event detection in flow cytometry.
- Statistical methods for the assessment of EQAPOL proficiency testing: ELISpot, Luminex, and Flow Cytometry.
- Surrogate markers of response to cancer immunotherapy.
- T-cell-directed cancer vaccines: the melanoma model.
- The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.
- The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.
- The Immunology Quality Assessment Proficiency Testing Program for CD3⁺4⁺ and CD3⁺8⁺ lymphocyte subsets: a ten year review via longitudinal mixed effects modeling.
- The eye: A window to the soul of the immune system.
- The role of quantitative PCR for the immune monitoring of cancer patients.
- Toward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokine staining assays.
- Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.